0 rating

The Management of Angle-Closure Glaucoma

Jovina LS See, MBBChir, FRCS, and Paul TK Chew, FRCS, FRCOphth
Int J Clin Rev 2010;11:09    doi: 10.5275/ijcr.2010.11.09

Glaucoma is the leading cause of irreversible blindness worldwide [1]. Based on several population studies, it has been projected that glaucoma will affect approximately 79.6 million people by 2020 [2]. Slightly more than one-quarter of these (26%) will have angle-closure glaucoma (ACG), accounting for 47% of the bilateral blindness related to glaucoma. As a result of its higher visual morbidity, the 5.3 million people who will be blinded by ACG is nearly equal to the number who will be blinded by open-angle glaucoma (OAG), despite the latter disease being three times more prevalent.

Return to top